CVRX
CVRx Inc.
$6.55
-$0.09(-1.36%)
38
Overall
55
Value
18
Tech
42
Quality
Market Cap
$182.42M
Volume
224.91K
52W Range
$4.30 - $15.42
Target Price
$11.50
Company Overview
| Mkt Cap | $182.42M | Price | $6.55 |
| Volume | 224.91K | Change | -1.36% |
| P/E Ratio | -3.0 | Open | $6.69 |
| Revenue | $51.3M | Prev Close | $6.64 |
| Net Income | $-60.0M | 52W Range | $4.30 - $15.42 |
| Div Yield | N/A | Target | $11.50 |
| Overall | 38 | Value | 55 |
| Quality | 42 | Technical | 18 |
No chart data available
About CVRx Inc.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Latest News
Lake Street Reaffirms Their Buy Rating on CVRx (CVRX)
TipRanks Auto-Generated Intelligence Newsdesk•3 days ago
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX)
Christine Brown•17 days ago
CVRx (CVRX) Gets a Buy from Lake Street
TipRanks Auto-Generated Intelligence Newsdesk•17 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVRX | $6.55 | -1.4% | 224.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |